Complex regional pain syndrome (CRPS) does not directly cause death. It is not a terminal illness, and the condition itself does not destroy organs or spread fatally through the body. But CRPS carries serious indirect risks to life, primarily through its connection to suicide, cardiovascular strain from chronic severe pain, and complications from aggressive treatments. These indirect threats are real enough that CRPS is sometimes called “the suicide disease.”
Why CRPS Is Called “The Suicide Disease”
CRPS consistently ranks among the most painful conditions known to medicine. On the McGill Pain Questionnaire, a standard tool for measuring pain intensity, CRPS patients score an average of 42 out of 50, higher than scores reported for limb amputation or childbirth. That level of pain, sustained over months or years, takes a profound toll on mental health.
In one epidemiological survey of CRPS patients, 46.4% reported experiencing suicidal thoughts, and 20% had attempted suicide. In a clinical study of 39 CRPS patients, nearly three-quarters fell into the high suicidal ideation group. The factors most strongly tied to suicide risk in these patients were depression, pain severity, and loss of daily functioning. The pain itself drives the crisis, but the inability to work, sleep, move normally, or participate in life compounds it.
How Chronic Severe Pain Affects the Heart
Living with intense, unrelenting pain puts long-term stress on the cardiovascular system. A systematic review and meta-analysis found that people with chronic pain have a 20% higher odds of dying from cardiovascular disease compared to people without chronic pain. The risk was even more pronounced for specific conditions: 73% higher odds of cardiac disease and 81% higher odds of cerebrovascular disease (stroke). The analysis also found a dose-response pattern, meaning the more severe the pain and the more widespread it is across the body, the stronger the link to heart problems.
CRPS specifically involves dysfunction of the autonomic nervous system, which controls heart rate, blood pressure, and blood vessel tone. Patients often show increased resting heart rate and reduced heart rate variability, both signs that the body is stuck in a sustained stress response. Over time, this kind of autonomic imbalance raises peripheral resistance in blood vessels and increases the workload on the heart. While no large study has isolated CRPS-specific cardiac mortality rates, the combination of extreme pain severity and documented autonomic dysfunction places these patients squarely in a higher-risk category.
Risks From CRPS Treatments
Some of the more aggressive treatments used for CRPS carry their own dangers. High-dose ketamine infusions, sometimes administered over days in an intensive care setting, can cause liver damage. In one clinical trial of repeated ketamine infusions for CRPS, half the participants developed elevated liver enzymes, and the study was stopped early. Ketamine also carries risks of nausea, cardiovascular stimulation, cognitive effects, and psychological disturbances. Some clinicians have compared the risk-benefit calculus of ketamine for CRPS to that of chemotherapy for cancer: potentially toxic, but sometimes justified if the pain is severe enough.
Spinal cord stimulators, implanted devices that deliver electrical signals to interrupt pain, are another common treatment. A 10-year survival analysis of 330 patients with chronic neuropathic pain found that patients who had a successful, permanent spinal cord stimulator showed no increased mortality compared to matched controls. However, patients whose stimulator trials failed or whose devices were later removed had significantly higher mortality rates, with hazard ratios of 2.34 and 3.57, respectively. This likely reflects the fact that patients who don’t respond to treatment continue to bear the full burden of uncontrolled pain, rather than the devices themselves causing harm.
Autonomic Dysfunction Beyond the Limb
CRPS is often thought of as a condition affecting one arm or leg, but its effects extend further. The autonomic nervous system dysfunction seen in CRPS can produce orthostatic hypotension (a drop in blood pressure when standing), abnormal sweating patterns, and heightened sensitivity of blood vessels to stress hormones. The sympathetic nervous system, which normally helps regulate blood flow to organs, becomes dysregulated. Below the injury site, nerves may become overly sensitive to adrenaline-like chemicals, while above the injury, sympathetic nerve activity may actually increase.
This creates a body-wide imbalance. Blood pressure may spike in response to pain, the heart works harder than it should at rest, and the normal fine-tuning of blood flow to organs is disrupted. None of this is immediately fatal, but over years it contributes to wear on the cardiovascular system that compounds the risks already associated with chronic severe pain.
What Actually Determines Long-Term Outcomes
The single biggest factor in CRPS prognosis is whether pain can be brought under some degree of control. Patients whose pain responds to treatment, whether through nerve blocks, physical therapy, spinal cord stimulation, or medication, tend to have better mental health outcomes, maintain more daily function, and avoid the cascading risks that come with uncontrolled pain. Patients whose pain remains refractory face compounding problems: deepening depression, physical deconditioning, social isolation, cardiovascular strain, and the risks that come with increasingly aggressive treatments.
Early and sustained treatment of depression is critical. Since depression, pain severity, and functional impairment are the three strongest predictors of suicidal ideation in CRPS patients, addressing all three simultaneously offers the best protection. CRPS itself won’t appear on a death certificate as a cause of death, but the suffering it causes can set in motion a chain of events, from mental health crises to cardiovascular damage, that genuinely threatens life.